HiberCell Announces Successful Completion and Interim

HiberCell Announces Successful Completion and Interim Results of Phase 1 Study of HC-5404 and Maps Forward Path as Monotherapy and in Combinations...

Related Keywords

Jonathan Lanfear ,Clinical Cancer Research ,Albert Einstein College Of Medicine ,Renal Cell Carcinoma ,Kinase Inhibitors ,Clinical Cancer ,Einstein College ,Albert Einstein College ,Unfolded Protein Response ,Hibercell ,Nc ,